Clinical trial
SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)
NCT00438568 · University of Washington, Other · Completed
Key facts
| NCT number | NCT00438568 |
|---|---|
| Title | SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days) |
| Official title | Therapeutic Effects of Intranasal Insulin Administration in AD |
| Acronym | SNIFF 120 |
| Lead sponsor | University of Washington, Other |
| Collaborators | National Institute on Aging (NIA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Mild Cognitive Impairment, Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | Regular Insulin, Placebo |
| Enrollment | 173 |
| Start date | Jun 1, 2006 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | Feb 22, 2007 |
| Last update posted | Sep 14, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: